Journal
Journal for Immunotherapy of Cancer
Publication Date
5-30-2025
Volume
13
Issue
5
First Page
e011363
Document Type
Open Access Publication
DOI
10.1136/jitc-2024-011363
Rights and Permissions
Zander AD, Erbe R, Liu Y, Jin A, Hyun SW, Mukhopadhyay S, Terdich B, Rosasco MG, Patel N, Mahon BM, Sasser AK, Ting-Lin MA, Nimeiri H, Guinney J, Adkins D, Zibelman M, Beauchamp KA, Sangli C, Stein MM, Taxter T, Chan T, Patel SP, Cohen EEW. Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors. J Immunother Cancer. 2025 May 30;13(5):e011363. doi: 10.1136/jitc-2024-011363. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license
Recommended Citation
Zander, Alia D; Adkins, Douglas; and et al., "Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors." Journal for Immunotherapy of Cancer. 13, 5. e011363 (2025).
https://digitalcommons.wustl.edu/oa_4/5553
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
